20.30
0.00
(0.00%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,086,000.00
667,000.00
416,000.00
468,000.00
301,000.00
Investing Cash Flow
-420,000.00
-375,000.00
-351,000.00
-266,000.00
-245,000.00
Financing Cash Flow
-310,000.00
-31,000.00
-42,000.00
-311,000.00
-62,000.00
End Cash Position
563,000.00
474,000.00
221,000.00
194,000.00
298,000.00
Capital Expenditure
-309,000.00
-379,000.00
-353,000.00
-263,000.00
-222,000.00
Issuance of Capital Stock
-33,000.00
-20,000.00
31,000.00
-41,000.00
-13,000.00
Issuance of Debt
596,000.00
671,000.00
60,000.00
226,000.00
--
Repayment of Debt
-817,000.00
-636,000.00
-94,000.00
-464,000.00
-19,000.00
Free Cash Flow
777,000.00
288,000.00
63,000.00
205,000.00
79,000.00
12/31/2020 - 11/16/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MMIRF MedMira Inc.
0.0131
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0600
+27.66%
AGN.CN Algernon Pharmaceuticals Inc.
0.0850
0.00%
PHRM.CN PharmaTher Holdings Ltd.
0.2150
-6.52%
IDYA IDEAYA Biosciences, Inc.
24.03
-3.30%
KAPA Kairos Pharma, Ltd.
0.9700
-5.83%
MDNA.TO Medicenna Therapeutics Corp.
1.3700
-5.52%
CEROW CERo Therapeutics Holdings, Inc.
0.0171
-12.31%
MIR.V MedMira Inc.
0.1300
0.00%